ISPOR 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
2024
May 5-8, 2024
Home
Events
Past Conferences
ISPOR 2024
Program
Plenary Sessions
Session
Identifying Eligibility for Chimeric Antigen Receptor T-Cell Therapy Among Diffuse Large B-Cell Lymphoma Patients Using Real-World Data and Unsupervised Machine Learning
May 6, 2024, 16:30 PM
«
1341
1342
1343
1344
1345
1346
1347
(current)
1348
1349
1350
»